LivaNova
Update in progressLIVN (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
LivaNova PLC is a medical technology company that designs, develops, manufactures, markets and sells cardiopulmonary and neuromodulation products worldwide. Cardiopulmonary offerings include heart-lung machines, oxygenators, perfusion tubing, cannulae and related services. Neuromodulation includes the VNS Therapy System (implantable pulse generator and lead), surgical equipment, and devices for drug-resistant epilepsy and refractory depression, plus aura6000 sleep apnea work in development. Sells through direct sales, agents and distributors. Incorporated 2015, HQ in London.
Company score
- Sentiment
- 0.35
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.38
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.36
- Governance
- 0.13
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.00
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.18
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited Kingdom
- CEOMr. Vladimir A. Makatsaria
- Founded2015
- Employees3,300
- Websitewww.livanova.com
Identifiers
- ISINGB00BYMT0J19
- FIGIBBG009LGHG16
- LEI2138001K2FX6SHK2B339
- CUSIPG5509L101
- CIK0001639691